HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta-analysis.
Lockart I, Yeo MGH, Hajarizadeh B, Dore GJ, Danta M.
Hepatology. 2022 Jul;76(1):139-154. doi: 10.1002/hep.32341. Epub 2022 Feb 7.
Concise review: Interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection.
Weiler N, Zeuzem S, Welker MW.
World J Gastroenterol. 2016 Nov 7;22(41):9044-9056. doi: 10.3748/wjg.v22.i41.9044.
Viral hepatitis C.
Poynard T, Yuen MF, Ratziu V, Lai CL.
Lancet. 2003 Dec 20;362(9401):2095-100. doi: 10.1016/s0140-6736(03)15109-4.
Mechanism of hepatitis C virus-mediated development and progression of liver cirrhosis and hepatocellular carcinoma.
Wan KR, Qian C, Liu LM.
World J Gastroenterol. 2026 Feb 21;32(7):115234. doi: 10.3748/wjg.v32.i7.115234.
Natural History of Hepatitis C.
Lingala S, Ghany MG.
Gastroenterol Clin North Am. 2015 Dec;44(4):717-34. doi: 10.1016/j.gtc.2015.07.003. Epub 2015 Aug 25.
Hepatitis C genotype 3 disease.
Kattakuzhy S, Levy R, Rosenthal E, Tang L, Wilson E, Kottilil S.
Hepatol Int. 2016 Nov;10(6):861-870. doi: 10.1007/s12072-016-9748-z. Epub 2016 Jun 21.
Should surveillance for liver cancer be modified in hepatitis C patients after treatment-related cirrhosis regression?
D'Ambrosio R, Colombo M.
Liver Int. 2016 Jun;36(6):783-90. doi: 10.1111/liv.13106. Epub 2016 Mar 24.
Treatment of chronic hepatitis C in patients with decompensated cirrhosis.
Everson GT.
Rev Gastroenterol Disord. 2004;4 Suppl 1:S31-8.
Chronic hepatitis C: Diagnosis and treatment made easy.
Abu-Freha N, Mathew Jacob B, Elhoashla A, Afawi Z, Abu-Hammad T, Elsana F, Paz S, Etzion O.
Eur J Gen Pract. 2022 Dec;28(1):102-108. doi: 10.1080/13814788.2022.2056161.
Sex-specific changes in triglyceride profiles in liver cirrhosis and hepatitis C virus infection.
Peschel G, Grimm J, Müller M, Höring M, Krautbauer S, Weigand K, Liebisch G, Buechler C.
Lipids Health Dis. 2022 Oct 24;21(1):106. doi: 10.1186/s12944-022-01715-w.
